Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
15.17
-0.41 (-2.63%)
Jul 31, 2026, 4:00 PM EDT - Market closed
Janux Therapeutics Market Cap
Janux Therapeutics has a market cap or net worth of $925.13 million as of July 31, 2026. Its market cap has decreased by -35.48% in one year.
Market Cap
925.13M
Enterprise Value
-9.68M
1-Year Change
-35.48%
Ranking
Category
Stock Price
$15.17
ChartMarket Cap Chart
Since the IPO on June 11, 2021, Janux Therapeutics's market cap has increased from $613.73M to $925.13M, an increase of 50.74%. That is a compound annual growth rate of 8.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 925.13M | 11.46% |
| Dec 31, 2025 | 830.04M | -73.11% |
| Dec 31, 2024 | 3.09B | 523.34% |
| Dec 29, 2023 | 495.20M | -9.51% |
| Dec 30, 2022 | 547.22M | -33.35% |
| Dec 31, 2021 | 821.00M | 33.77% |
| Jun 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avalo Therapeutics | 1.01B |
| EyePoint | 999.39M |
| Olema Pharmaceuticals | 977.42M |
| Sana Biotechnology | 950.68M |
| Phathom Pharmaceuticals | 924.57M |
| Geron | 898.13M |
| Pharming Group | 882.92M |
| Theravance Biopharma | 873.31M |